Twist Bioscience (TWST) Competitors $27.95 +0.98 (+3.63%) Closing price 04:00 PM EasternExtended Trading$27.85 -0.10 (-0.36%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST vs. ADPT, BEAM, CRSP, NTLA, TXG, VCYT, CYTK, RNA, NUVL, and TGTXShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Adaptive Biotechnologies (ADPT), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Intellia Therapeutics (NTLA), 10x Genomics (TXG), Veracyte (VCYT), Cytokinetics (CYTK), Avidity Biosciences (RNA), Nuvalent (NUVL), and TG Therapeutics (TGTX). These companies are all part of the "medical" sector. Twist Bioscience vs. Its Competitors Adaptive Biotechnologies Beam Therapeutics CRISPR Therapeutics Intellia Therapeutics 10x Genomics Veracyte Cytokinetics Avidity Biosciences Nuvalent TG Therapeutics Adaptive Biotechnologies (NASDAQ:ADPT) and Twist Bioscience (NASDAQ:TWST) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Do analysts rate ADPT or TWST? Adaptive Biotechnologies currently has a consensus price target of $12.38, indicating a potential downside of 10.13%. Twist Bioscience has a consensus price target of $49.40, indicating a potential upside of 76.74%. Given Twist Bioscience's higher probable upside, analysts plainly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.73 Is ADPT or TWST more profitable? Twist Bioscience has a net margin of -23.51% compared to Adaptive Biotechnologies' net margin of -59.07%. Twist Bioscience's return on equity of -29.03% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-59.07% -60.93% -23.03% Twist Bioscience -23.51%-29.03%-21.77% Does the media prefer ADPT or TWST? In the previous week, Twist Bioscience had 7 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 13 mentions for Twist Bioscience and 6 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 1.14 beat Twist Bioscience's score of 0.92 indicating that Adaptive Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 5 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Twist Bioscience 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders have more ownership in ADPT or TWST? 99.2% of Adaptive Biotechnologies shares are owned by institutional investors. 6.4% of Adaptive Biotechnologies shares are owned by insiders. Comparatively, 3.0% of Twist Bioscience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has preferable earnings and valuation, ADPT or TWST? Adaptive Biotechnologies has higher earnings, but lower revenue than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$178.96M11.72-$159.49M-$0.82-16.79Twist Bioscience$312.97M5.39-$208.73M-$1.45-19.28 Which has more risk & volatility, ADPT or TWST? Adaptive Biotechnologies has a beta of 1.93, suggesting that its stock price is 93% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.31, suggesting that its stock price is 131% more volatile than the S&P 500. SummaryTwist Bioscience beats Adaptive Biotechnologies on 8 of the 15 factors compared between the two stocks. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TWST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.63B$3.13B$5.81B$10.33BDividend YieldN/A2.37%5.86%4.62%P/E RatioN/A21.3676.9326.98Price / Sales5.39251.85450.4089.35Price / CashN/A45.4837.2260.63Price / Book3.469.6913.836.37Net Income-$208.73M-$52.92M$3.29B$271.46M7 Day Performance9.14%1.44%0.93%2.35%1 Month Performance-0.25%6.03%5.31%7.78%1 Year Performance-40.56%12.89%84.25%32.27% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience4.0192 of 5 stars$27.95+3.6%$49.40+76.7%-43.4%$1.63B$312.97M0.00990Gap UpADPTAdaptive Biotechnologies3.4768 of 5 stars$12.54-2.4%$12.38-1.3%+176.9%$1.91B$178.96M-15.29790Positive NewsBEAMBeam Therapeutics3.2099 of 5 stars$19.94-4.5%$48.45+143.0%-12.2%$2.02B$63.52M-4.43510Analyst ForecastGap UpHigh Trading VolumeCRSPCRISPR Therapeutics3.0994 of 5 stars$54.10-1.4%$71.60+32.3%+18.4%$4.92B$37.31M-9.96460News CoverageAnalyst ForecastGap UpNTLAIntellia Therapeutics4.5066 of 5 stars$11.84-1.8%$29.05+145.4%-45.0%$1.27B$57.88M-2.52600News CoverageOptions VolumeGap UpTXG10x Genomics3.5225 of 5 stars$13.93-0.2%$13.54-2.8%-39.9%$1.73B$644.47M-19.901,240Gap UpVCYTVeracyte3.8 of 5 stars$32.46+0.1%$40.90+26.0%-7.3%$2.55B$445.76M98.37790Positive NewsCYTKCytokinetics4.3776 of 5 stars$52.09-1.7%$75.38+44.7%-15.3%$6.23B$18.47M-10.21250Trending NewsInsider TradeRNAAvidity Biosciences2.1548 of 5 stars$48.05-4.6%$67.00+39.4%-5.0%$6.18B$10.90M-13.50190Analyst ForecastNUVLNuvalent3.1618 of 5 stars$79.83-1.3%$120.91+51.5%-24.9%$5.76BN/A-16.2940Insider TradeTGTXTG Therapeutics4.3823 of 5 stars$32.38+0.5%$46.25+42.8%+27.8%$5.14B$329M87.51290News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Adaptive Biotechnologies Alternatives Beam Therapeutics Alternatives CRISPR Therapeutics Alternatives Intellia Therapeutics Alternatives 10x Genomics Alternatives Veracyte Alternatives Cytokinetics Alternatives Avidity Biosciences Alternatives Nuvalent Alternatives TG Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TWST) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredReagan’s former tech advisor sharing bombshell announcementGeorge Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TWST Stock Alerts